基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 生化试剂 激动剂抑制剂 2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 化合物 GSK650394
  • 化合物 GSK650394|T2622|TargetMol

化合物 GSK650394|T2622|TargetMol

GSK 650394
890842-28-1
298 1mg 起订
423 2mg 起订
663 5mg 起订
上海 更新日期:2024-09-30

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 GSK650394
英文名称:
GSK 650394
CAS号:
890842-28-1
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
98.93%
产品类别:
抑制剂
货号:
T2622

Product Introduction

Bioactivity

名称GSK 650394
描述GSK 650394 is an inhibitor of serum- and glucocorticoid-regulated kinases (SGK) that inhibits SGK1 and SGK2 (IC50=62/103 nM). GSK 650394 has antitumor activity and also inhibits osteoclast differentiation and prevents bone loss.
细胞实验LNCaP cells are plated at a density of 5,000 cells per well in 96-well plates in 100 μL PRF-RPMI 1640, supplemented with 8% CS-FBS, 0.1 mM NEAA, and 1 mM NaPyr. At day three, cells are treated with hormone with or without GSK650394 by removing 50 μL of the media and replacing this with 50 μL of PRF-RPMI 1640 with 8% CS-FBS, NEAA, NaPyr containing a 2X concentration of the appropriate hormone/inhibitor treatment. At days 5 and 7, the treatment is repeated. On the tenth day, the media is removed and the relative cell number is measured using the FluoReporter Blue assay according to the manufacturer's instructions.(Only for Reference)
激酶实验Scintillation proximity assay (SPA): SGK1 S422D (60–431 aa; 0.275 μg/mL final concentration) or SGK2 (0.875 μg/mL final concentration) are activated by PDK1 (1.1 μg/mL final concentration) in a buffer consisting of 50 mM Tris (pH 7.5), 0.1 mM EGTA, 0.1 mM EDTA, 10 mM MgCl2, 0.1% β-mercaptoethanol, 1 mg/mL BSA, and ATP (final concentration of 0.15 mM) and incubated for 30 min at 30°C. SGK2 is prepared exactly as described for SGK1, except it corresponded to the full-length protein. A solution containing biotinylated CROSStide peptide at a final concentration of 75 μM and γ32P-ATP corresponding to 2×106 cpm is prepared in the reaction buffer. In a 96-well plate, 5 μL of GSK650394 is added to 25 μL of the activated enzyme mixture. To this, 20 μL of the CROSStide mixture is added and incubated for 1 h at room temperature. Next, 50 μL of a 25 mg/mL slurry of streptavidin-coated SPA beads in PBS with 0.1 M EDTA, pH 8.0 is added. The plate is then sealed and centrifuged for 8 min at 2000 rpm, and the signal is detected by measuring for 30 sec/well in a Packard TopCount NXT Scintillation Counter. The IC50 values of the inhibition of SGK1 and SGK2 activities by GSK650394 are calculated from these data using GraphPad Prism 3 Software.
体外活性方法:LNCaP 细胞用 GSK 650394 (0.1-10 µM) 和 R1881 (1 nM) 处理 24-48 h,通过 Western Blot 检测靶点蛋白表达水平。 结果:GSK 650394 抑制了雄激素介导的 Nedd4-2 磷酸化增强,表明 GSK 650394 拮抗了细胞中的 SGK1 活性。[1] 方法:肿瘤细胞 HeLa 和 HepG2 用 GSK 650394 (3.12-12.5 µM) 处理 24-72 h,通过 MTT assay 测定细胞活力。 结果:用 GSK 650394 处理的细胞以剂量依赖的方式显示出显著的生长抑制作用。[2]
体内活性方法:为研究对骨质疏松症的作用,将 GSK 650394 (10-30 mg/kg) 腹腔注射给卵巢切除诱导的骨丢失小鼠,每周三次,持续八周。 结果:GSK 650394 治疗改善了卵巢切除诱导的骨丢失小鼠的骨密度。GSK 650394 治疗可以提高体内抗氧化酶的能力。研究表明,GSK 650394 可以抑制破骨细胞的活化,因此可能是治疗破骨细胞活化相关骨质疏松症的潜在治疗试剂。[3]
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 50 mg/mL (130.74 mM)
关键字GSK 650394 | Influenza Virus | inhibit | Serum-glucocorticoid regulated kinase | Inhibitor | Serum and glucocorticoid-regulated kinase | GSK-650394 | SGK
相关产品Crystal Violet | N-Acetylneuraminic acid | Camphor | Salcomine | β-Cyclodextrin | Nitazoxanide | Curcumin | α-Vitamin E | Acetylcysteine | Naringenin | Rifampicin | AEBSF hydrochloride
相关库抑制剂库 | 经典已知活性库 | 已知活性化合物库 | 代谢化合物库 | 抗感染化合物库 | 激酶抑制剂库 | NO PAINS 化合物库 | 抗病毒库 | 糖代谢化合物库 | 抗代谢疾病化合物库
GSK650394|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 GSK650394相关厂家报价

内容声明
拨打电话 立即询价